Site is currently under maintenance
Some features may be unavailable or limited during this time. We apologize for any inconvenience and appreciate your patience.

Published on 01 January 2022

A Phase III, Multicentre, Prospective, Double Blind, Randomised, Placebo Controlled Study, Assessing the Efficacy and Safety of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury

View Dataset
Ipsen

Description

The purpose of this research study is to assess the efficacy of Dysport compared to placebo in improving muscle tone in hemiparetic subjects with upper limb spasticity due to stroke or traumatic brain injury.

Citations (0)

Mentions (0)

Metrics

Dataset Index

1.0

FAIR Score

46%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Vivli

Assigned Domain

Subfield

Epidemiology

Field

Medicine

Domain

Health Sciences

Confidence Score

53%

Source

Scholar Data Model

Keywords

Conditions: Nervous System DisordersInterventions: Botulinum toxin type AInterventions: Placebo

Normalization Factors

FT

15.38

CTw

1.00

MTw

1.00